Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beom K Choi

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Experimental & Molecular Medicine|September 12, 2009
Expression of 4-1BB and 4-1BBL in thymocytes during thymus regenerationYoung-Mi Kim, Hye Kyung Kim, Hyo Jin Kim, et al.
Cancer|June 28, 2024
Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancerHyunsoon Cho, Hoejun Kwon, Se Hyun Kim, et al.
Cytotherapy|August 26, 2023
Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumorsWonyoung Choi, Youngjoo Lee, Beom K Choi, et al.
Molecular Therapy Oncolytics|May 6, 2020
Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen ReceptorChungyong Han, Beom K Choi, Seon-Hee Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2011
4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cellsYoung H Kim, Beom K Choi, Su M Shin, et al.
International Journal of Molecular Sciences|September 28, 2023
Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8<sup>+</sup> T Cell ResponsesEunjung Cho, Seongeun Han, Hyeon Seok Eom, et al.
Cellular & Molecular Immunology|September 2, 2020
Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8<sup>+</sup> T cell responsesSeon-Hee Kim, Rohit Singh, Chungyong Han, et al.
Nature Communications|February 3, 2018
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expressionChungyong Han, Su-Jung Sim, Seon-Hee Kim, et al.
Frontiers in Immunology|November 25, 2021
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical StudyKiwan Kim, Ho-Shin Gwak, Nayoung Han, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
4-1BB-based isolation and expansion of CD8+ T cells specific for self-tumor and non-self-tumor antigens for adoptive T-cell therapyBeom K Choi, Sang C Lee, Myoung J Lee, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Experimental & Molecular Medicine|September 12, 2009
Expression of 4-1BB and 4-1BBL in thymocytes during thymus regenerationYoung-Mi Kim, Hye Kyung Kim, Hyo Jin Kim, et al.
Cancer|June 28, 2024
Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancerHyunsoon Cho, Hoejun Kwon, Se Hyun Kim, et al.
Cytotherapy|August 26, 2023
Phase 1 trial of 4-1BB-based adoptive T-cell therapy targeting human telomerase reverse transcriptase in patients with advanced refractory solid tumorsWonyoung Choi, Youngjoo Lee, Beom K Choi, et al.
Molecular Therapy Oncolytics|May 6, 2020
Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen ReceptorChungyong Han, Beom K Choi, Seon-Hee Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2011
4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cellsYoung H Kim, Beom K Choi, Su M Shin, et al.
International Journal of Molecular Sciences|September 28, 2023
Cross-Activation of Regulatory T Cells by Self Antigens Limits Self-Reactive and Activated CD8<sup>+</sup> T Cell ResponsesEunjung Cho, Seongeun Han, Hyeon Seok Eom, et al.
Cellular & Molecular Immunology|September 2, 2020
Chronic activation of 4-1BB signaling induces granuloma development in tumor-draining lymph nodes that is detrimental to subsequent CD8<sup>+</sup> T cell responsesSeon-Hee Kim, Rohit Singh, Chungyong Han, et al.
Nature Communications|February 3, 2018
Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expressionChungyong Han, Su-Jung Sim, Seon-Hee Kim, et al.
Frontiers in Immunology|November 25, 2021
Chimeric Antigen Receptor T Cells With Modified Interleukin-13 Preferentially Recognize IL13Rα2 and Suppress Malignant Glioma: A Preclinical StudyKiwan Kim, Ho-Shin Gwak, Nayoung Han, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
4-1BB-based isolation and expansion of CD8+ T cells specific for self-tumor and non-self-tumor antigens for adoptive T-cell therapyBeom K Choi, Sang C Lee, Myoung J Lee, et al.
Pageof 7